Investing Profile

Christopher R. Shepard

InvestorVC
Medical Scientist and Venture Partner, Apollo Health Ventures
apollo.vc/teamNew York, New York
Photo of Christopher R. Shepard, Venture Partner at Apollo Health Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
University of Sydney Network
19 CONNECTIONS
Carnegie Mellon University - Tepper School of Business Network
17 CONNECTIONS
Genentech Network
12 CONNECTIONS
Genentech Network
12 CONNECTIONS
cb
Apollo Health Ventures Venture Partner
$100K - $5.0M
$1.5M
Director Avogadro Development Corp2023 - Present
Board Trustee Prostate Cancer Research2021 - Present
Venture Partner Apollo Health Ventures2021 - Present
Chief Executive Officer, Director Avogadro Development Corp2019 - 2022
Director Carnot BioSciences, LLC2018 - 2022
Director Structured BioEquity SBE2017 - 2022
GM/Chief Executive, Director (US) Smartzyme Biopharma2018 - 2019
Chief Development Officer Smartzyme Biopharma2017 - 2018
Senior Vice President, Business and Portfolio Development Smartzyme Biopharma2017 - 2017
R&D Technical Evaluation (Translational - Phase 2) and Transactions Structured BioEquity SBE2013 - 2017
Principal and North America Leadership Team Deallus Consulting2012 - 2013
Business Unit Manager Deallus Consulting2012 - 2012
Senior Consultant Deallus Consulting2011 - 2012
Consultant Deallus Consulting2011 - 2011
Competitive Intelligence Genentech2009 - 2009
Scientist Massachusetts Institute of Technology2007 - 2008
Principal Investigator (Congressionally Directed Medical Programs for the Department of Defense) University of Pittsburgh School of Medicine2005 - 2007
Safety Assessment Pathology Genentech2002 - 2002
University of Pittsburgh School of Medicine PhD (Honors) Molecular and Cellular Pathology
Carnegie Mellon University - Tepper School of Business MBA Finance
Wake Forest University BSc Biology
University of Sydney Honors Work Statistical Physics